Scynexis Europe has chosen advanced evaporation technology from Genevac for a new "Hit Factory" being built just outside London, UK.
Scynexis Europe has chosen advanced evaporation technology from Genevac for a new "Hit Factory" being built just outside London, UK.
The new Genevac Mega 1200 evaporator is capable of handling large numbers of tubes, vials and microplates and can even accept whole racks from HPLC fraction collectors such as those available from Waters or Gilson.
The Mega 1200 systems will form an integral part of Scynexis' new Hit Factory - an industrialised drug discovery compound production laboratory capable of delivering millions of screening compounds per year.
In near continuous use, the MEGA 1200 will be exclusively responsible for drying down purified fractions from Scynexis' preparative HPLC systems.
Following reformatting onto plates, further large scale evaporation capacity will be provided by a Genevac HT-12 system, enabling customers to specify dry compounds on plates for delivery and storage, thereby offering convenient and cheap compound logistics.
Scynexis, which is headquartered at Research Triangle Park in the USA, chose Genevac for its advanced drying technology, which gives class-leading contamination control and ultra high-throughput solvent removal from a wide variety of sample formats.
